Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-296-3 | CAS number: 56-89-3
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
IUCLID section 7.8.1:
L-Cystine (and L-Cysteine respectively) is an amino acid that is required for normal functioning of humans. The substance is of low toxicological activity and subject to homeostasis. Therefore, reprotoxic effects are not expected for L-Cystine and no test is required for this substance. There is sufficient weight of evidence for the absence of reprotoxic effects. A screening for reproductive toxicity (REACH Annex VIII No. 8.7.1) as well as any study on reproductive toxicity as REACH Annex IX no. 8.7 are not to be conducted in accordance with REACH Annex XI no. 1.2. and for reasons of animal welfare: "Where sufficient weight of evidence for the presence or absence of a particular dangerous property is available, further testing on vertebrate animals for this property shall be omitted..."
IUCLID section 7.8.2:
L-Cystine (and L-Cysteine respectively) is an amino acid that is required for normal functioning of humans. The substance is of low toxicological activity and subject to homeostasis. Therefore, reprotoxic effects are not expected for L-Cystine and no test is required for this substance. There is sufficient weight of evidence for the absence of reprotoxic effects. A screening for reproductive toxicity (REACH Annex VIII No. 8.7.1) as well as any study on reproductive toxicity as REACH Annex IX no. 8.7 are not to be conducted in accordance with REACH Annex XI no. 1.2. and for reasons of animal welfare: "Where sufficient weight of evidence for the presence or absence of a particular dangerous property is available, further testing on vertebrate animals for this property shall be omitted..."
Short description of key information:
Waiver: L-Cystine showed no effects on the reproductive organs in general repeated dose toxicity studies. There have been numerous studies in ex-perimental animals in which diets containing excess or inadequate levels of specific amino acids have been investigated. However these have been designed to investigate nutritional and/or metabolic consequences and not the possible adverse effects at high doses. It can be stated that amino acids are generally quickly absorbed and utilised in the mammal metabolism. Excess amino acid can be degraded, utilised as synthetic starting mate-rial for endogenous substances or as energy and excreted via effective metabolic pathways and will not accumulate.
Justification for classification or non-classification
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
